Trial Profile
Multicenter, Prospective, OL, Single-arm Clinical Study of Safety & Feasibility of Using Navigational Bronchoscopy to Perform Interstitial PD Therapy Using Photofrin® as Treatment in Subjects With Unresectable Solid Tumor in Peripheral Lung
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors ADVANZ PHARMA
- 19 Jul 2019 Status changed from active, no longer recruiting to completed.
- 04 Jan 2019 Planned End Date changed from 1 May 2019 to 1 May 2019.
- 04 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 April 2019.